Insmed Incorporated (BMV:INSM)

Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of MXN 750.55 billion. The enterprise value is 733.10 billion.

Market Cap	750.55B
Enterprise Value	733.10B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	211.37M
Shares Outstanding	n/a
Shares Change (YoY)	+22.43%
Shares Change (QoQ)	+11.86%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	90.56%
Float	192.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	91.54
PB Ratio	43.27
P/TBV Ratio	54.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-33.76
EV / Sales	88.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.11

Financial Position

The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.78.

Current Ratio	4.63
Quick Ratio	4.18
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	-0.82
Interest Coverage	-11.81

Financial Efficiency

Return on equity (ROE) is -165.69% and return on invested capital (ROIC) is -37.18%.

Return on Equity (ROE)	-165.69%
Return on Assets (ROA)	-28.05%
Return on Invested Capital (ROIC)	-37.18%
Return on Capital Employed (ROCE)	-50.95%
Revenue Per Employee	6.45M
Profits Per Employee	-17.08M
Employee Count	1,271
Asset Turnover	0.20
Inventory Turnover	0.96

Taxes

In the past 12 months, Insmed has paid 86.96 million in taxes.

Income Tax	86.96M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.85

Income Statement

In the last 12 months, Insmed had revenue of MXN 8.20 billion and -21.71 billion in losses. Loss per share was -114.08.

Revenue	8.20B
Gross Profit	6.28B
Operating Income	-18.16B
Pretax Income	-21.63B
Net Income	-21.71B
EBITDA	-17.95B
EBIT	-18.16B
Loss Per Share	-114.08

Balance Sheet

The company has 30.81 billion in cash and 13.58 billion in debt, giving a net cash position of 17.24 billion.

Cash & Cash Equivalents	30.81B
Total Debt	13.58B
Net Cash	17.24B
Net Cash Per Share	n/a
Equity (Book Value)	17.34B
Book Value Per Share	81.59
Working Capital	27.78B

Cash Flow

In the last 12 months, operating cash flow was -16.20 billion and capital expenditures -417.17 million, giving a free cash flow of -16.62 billion.

Operating Cash Flow	-16.20B
Capital Expenditures	-417.17M
Free Cash Flow	-16.62B
FCF Per Share	n/a

Margins

Gross margin is 76.54%, with operating and profit margins of -221.53% and -264.83%.

Gross Margin	76.54%
Operating Margin	-221.53%
Pretax Margin	-263.77%
Profit Margin	-264.83%
EBITDA Margin	-218.96%
EBIT Margin	-221.53%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.43%
Shareholder Yield	-22.43%
Earnings Yield	-2.89%
FCF Yield	-2.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of 3.4 and a Piotroski F-Score of 2.

Altman Z-Score	3.4
Piotroski F-Score	2